Neurotechnology is a revolutionary field that promises to relieve the unrelenting burden of brain diseases on patients and our healthcare system. The population is aging, and not only will the percentage of chronic brain diseases increase, but also those of vision and hearing. In 2019 there were an estimated 50,000 people in the Netherlands with Parkinson’s disease, 250,000 people who had suffered a stroke, and 300,000 people with impaired vision, and the combined economic burden from these 3 groups alone has reached 5 billion euros.
NeuroTech-NL establishes a program that connects the development of technology platforms with direct interfaces with the brain and nervous system, creating major breakthroughs for patients involving 21st century solutions that allow for stimulation and recordings in healthy as well as pathological neural tissue. The multidisciplinary co-development between clinical aims and technological innovations creates cross-pollination between applications: the results from solutions for one patient group can be leveraged to any other disease area that requires both “reading” and “writing” in the brain.